Update on real-world efficacy of anlotinib in non-small cell lung cancer

被引：0
|
作者：
Gao, Junzhen
Xu, Yan
Liu, Yonggang
Liang, Li
Yu, Yan
Zhao, Dahai
Jin, Jiahui
Wang, Mengzhao
机构：
[1] Inner Mongolia Med Univ, Affiliated Hosp, Hohhot, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China
[3] Baotou Tumor Hosp, Baotou, Peoples R China
[4] Peking Univ Third Hosp, Beijing, Peoples R China
[5] Harbin Med Canc Hosp, Harbin, Peoples R China
[6] Second Affiliated Hosp, Hefei, Peoples R China
[7] Affiliated Qingdao Cent Hosp, Qingdao, Peoples R China
[8] Peking Union Med Coll Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21173
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
    Fen Wang
    Feng Jin
    Boran Cheng
    Yue Zhang
    Qing Zhou
    Shubin Wang
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 1721 - 1735
  • [2] The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
    Wang, Fen
    Jin, Feng
    Cheng, Boran
    Zhang, Yue
    Zhou, Qing
    Wang, Shubin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (07) : 1721 - 1735
  • [3] A real-world study update: Efficacy and safety of anlotinib for advanced non-small cell lung cancer.
    Wang, Jinlin
    Yi, Tienan
    Dong, Youhong
    Xu, Xinhua
    Cao, Fengjun
    Ran, Ruizhi
    Yin, Yifa
    Li, Yinping
    Fu, Yang
    Xu, Yanhua
    Kuang, Li
    Chen, Guiming
    Qu, Guangqiao
    Li, Jun
    Luo, Zhiguo
    Chen, Yuan
    Song, Qibin
    Chu, Qian
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Zhang, Kun
    Ma, Xiya
    Gao, Hongjun
    Wang, Hong
    Qin, Haifeng
    Yang, Shaoxing
    Liu, Xiaoqing
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3409 - 3417
  • [5] The Real-World Efficacy and Safety of Anlotinib Treatment for Advanced Non-Small Cell Lung Cancer
    Wang, F.
    Jin, F.
    Wang, S.
    Zhu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S673 - S673
  • [6] A Real-World Study: Efficacy and Safety of Anlotinib for Advanced Non-Small Cell Lung Cancer
    Wang, J.
    Yi, T.
    Dong, Y.
    Ran, R.
    Cao, F.
    Li, Y.
    Luo, Z.
    Xu, Y.
    Fu, Y.
    Kuang, L.
    Chen, G.
    Qu, G.
    Yin, Y.
    Li, J.
    Xu, X.
    Chen, Y.
    Song, Q.
    Chu, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1071 - S1071
  • [7] Real-World Efficacy and Safety of Anlotinib with and without Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Xiong, Q.
    Qin, B.
    Xin, L.
    Yang, B.
    Hu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S676 - S676
  • [8] Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Xiong, Qi
    Qin, Boyu
    Xin, Lingli
    Yang, Bo
    Song, Qi
    Wang, Yu
    Zhang, Sujie
    Hu, Yi
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Efficacy and Safety of Anlotinib in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Zhong, Qiuxia
    Liu, Zhihua
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4115 - 4128
  • [10] Efficacy and Safety of Anlotinib-Containing Regimens in Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Sun, Lei
    Zhao, Qi
    Wang, Yanning
    Wang, Yongsheng
    Zheng, Ming
    Ding, Xuansheng
    Miao, Liyun
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 4165 - 4179
12345